News
It's a debilitating disease that affects more than 500,000 Australians, but new research from the University of South ...
Researchers called for standardized health outcome descriptors to help bridge communication gaps in rheumatology care and ...
AbbVie said on Monday it would acquire privately held cell therapy developer Capstan Therapeutics in a deal worth up to $2.1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results